Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-000508

Options or other derivatives

  • SENIOR VP, HEAD OF CMC acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ginski Mark J SENIOR VP, HEAD OF CMC 2021-02-01 Grant or award · Stock Options (Right to Buy) +200,000 200,000 D
Loading xslF345X03/form4-02022021_020242.xml…